BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22967672)

  • 1. The C-terminal domain of the heavy chain of tetanus toxin given by intramuscular injection causes neuroprotection and improves the motor behavior in rats treated with 6-hydroxydopamine.
    Mendieta L; Bautista E; Sánchez A; Guevara J; Herrando-Grabulosa M; Moran J; Martínez R; Aguilera J; Limón ID
    Neurosci Res; 2012 Oct; 74(2):156-67. PubMed ID: 22967672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carboxyl-terminal domain of the heavy chain of tetanus toxin prevents dopaminergic degeneration and improves motor behavior in rats with striatal MPP(+)-lesions.
    Mendieta L; Venegas B; Moreno N; Patricio A; Martínez I; Aguilera J; Limón ID
    Neurosci Res; 2009 Sep; 65(1):98-106. PubMed ID: 19523997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The restorative effect of intramuscular injection of tetanus toxin C-fragment in hemiparkinsonian rats.
    Sánchez-González A; Mendieta L; Palafox V; Candalija A; Luna F; Aguilera J; Limón ID
    Neurosci Res; 2014 Jul; 84():1-9. PubMed ID: 24815514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Administration of Tetanus Toxin Hc Fragment Prevents MPP
    Moreno-Galarza N; Mendieta L; Palafox-Sánchez V; Herrando-Grabulosa M; Gil C; Limón DI; Aguilera J
    Neurotox Res; 2018 Jul; 34(1):47-61. PubMed ID: 29460114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.
    Mendieta L; Granado N; Aguilera J; Tizabi Y; Moratalla R
    Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 26945022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson's Disease.
    Patricio F; Parra I; Martínez I; Pérez-Severiano F; Montes S; Aguilera J; Limón ID; Tizabi Y; Mendieta L
    Neurotox Res; 2019 Apr; 35(3):699-710. PubMed ID: 30607904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the C-terminal domain of the heavy chain of tetanus toxin on dyskinesia caused by levodopa in 6-hydroxydopamine-lesioned rats.
    Palafox-Sánchez V; Mendieta L; Ramírez-García G; Candalija A; Aguilera J; Limón ID
    Pharmacol Biochem Behav; 2016 Jun; 145():33-44. PubMed ID: 27090294
    [No Abstract]   [Full Text] [Related]  

  • 9. The recombinant C-terminal fragment of tetanus toxin protects against cholinotoxicity by intraseptal injection of β-amyloid peptide (25-35) in rats.
    Patricio-Martínez A; Mendieta L; Martínez I; Aguilera J; Limón ID
    Neuroscience; 2016 Feb; 315():18-30. PubMed ID: 26687435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant effects of C-Terminal domain of the heavy chain of tetanus toxin in a rat model of depression.
    Getachew B; Mendieta L; Csoka AB; Aguilera J; Tizabi Y
    Behav Brain Res; 2019 Sep; 370():111968. PubMed ID: 31125623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson's disease.
    Patricio F; Juárez-Torres D; Patricio-Martínez A; Mendieta L; Pérez-Severiano F; Montes S; Aguilera J; Limón ID
    Neurosci Res; 2022 Jan; 174():36-45. PubMed ID: 34453989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.
    Armentero MT; Levandis G; Bazzini E; Cerri S; Ghezzi C; Blandini F
    Neurobiol Dis; 2011 Sep; 43(3):663-8. PubMed ID: 21684338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration.
    Mabandla MV; Nyoka M; Daniels WM
    Brain Res; 2015 Oct; 1622():64-71. PubMed ID: 26111646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.
    Tsuboi K; Shults CW
    Exp Neurol; 2002 Jan; 173(1):95-104. PubMed ID: 11771942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
    Pinna A; Tronci E; Schintu N; Simola N; Volpini R; Pontis S; Cristalli G; Morelli M
    Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats.
    Hegazy MA; Maklad HM; Samy DM; Abdelmonsif DA; El Sabaa BM; Elnozahy FY
    Neurochem Int; 2017 Sep; 108():361-371. PubMed ID: 28527632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exacerbates [corrected] parkinsonian symptoms.
    Chao OY; Huston JP; von Bothmer A; Pum ME
    Neuroscience; 2011 Nov; 196():228-36. PubMed ID: 21888950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism.
    Borah A; Mohanakumar KP
    Brain Res; 2010 Jul; 1344():192-9. PubMed ID: 20470760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.